Comparison of Outcomes When Switching Treatment From Intravitreal Bevacizumab to Ranibizumab in Neovascular Age-Related Macular Degeneration

被引：0
|
作者：
Kent, J. S. [1 ]
Lordanous, Y. [1 ]
Mao, A. [1 ]
Shukla, S. [1 ]
Sheidow, T. [1 ]
机构：
[1] Univ Western Ontario, Dept Ophthalmol, London, ON, Canada
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
age-related macular degeneration; clinical (human) or epidemiologic studies: outcomes/complications; vascular endothelial growth factor;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
82
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Intravitreal aflibercept outcomes in patients with persistent retinal fluid with prior bevacizumab or ranibizumab treatment for neovascular age-related macular degeneration
    Griffin, David
    Richmond, Preston
    Olson, John
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [22] Cost Comparison of Intravitreal Aflibercept With Bevacizumab and Ranibizumab for the Treatment of Wet Age-Related Macular Degeneration
    Shaikh, Adeel H.
    Toussaint, Brian W.
    Miller, Daniel M.
    Petersen, Michael R.
    Foster, Robert E.
    Riemann, Christopher D.
    Hutchins, Robert K.
    Sisk, Robert A.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (01): : 62 - 66
  • [23] SWITCHING TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION FROM BEVACIZUMAB TO RANIBIZUMAB Who is Likely to Benefit From the Switch?
    Moisseiev, Elad
    Katz, Gabriel
    Moisseiev, Joseph
    Loewenstein, Anat
    Goldstein, Michaella
    Lomnicky, Yosef
    Abend, Yitzhak
    Treister, Giora
    Goldenberg, Dafna
    Levkovitch-Verbin, Hana
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (07): : 1323 - 1330
  • [24] Comparative Study of Intravitreal Bevacizumab (Avastin) versus Ranibizumab (Lucentis) in the Treatment of Neovascular Age-Related Macular Degeneration
    Landa, Gennady
    Amde, Wendewessen
    Doshi, Vatsal
    Ali, Amro
    McGevna, Laura
    Gentile, Ronald C.
    Muldoon, Thomas O.
    Walsh, Joseph B.
    Rosen, Richard B.
    [J]. OPHTHALMOLOGICA, 2009, 223 (06) : 370 - 375
  • [25] Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
    Griffin, David R.
    Richmond, Preston P.
    Olson, John C.
    [J]. JOURNAL OF OPHTHALMOLOGY, 2014, 2014
  • [26] Intravitreal bevacizumab treatment for neovascular age-related macular degeneration and thromboembolic events
    Weinstein, Orly
    Abu Tailakh, Muhammad
    Lifshitz, Tova
    Novack, Victor
    Levy, Jaime
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (01) : 66 - 71
  • [27] METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Kim, Leah N.
    Mehta, Hemal
    Barthelmes, Daniel
    Vuong Nguyen
    Gillies, Mark C.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (08): : 1418 - 1431
  • [28] Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration
    Mantel, Irmela
    Gillies, Mark C.
    Souied, Eric H.
    [J]. SURVEY OF OPHTHALMOLOGY, 2018, 63 (05) : 638 - 645
  • [29] Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
    Chakravarthy, Usha
    Harding, Simon P.
    Rogers, Chris A.
    Downes, Susan M.
    Lotery, Andrew J.
    Wordsworth, Sarah
    Reeves, Barnaby C.
    [J]. OPHTHALMOLOGY, 2012, 119 (07)
  • [30] PROGNOSTIC FACTORS AND OUTCOME OF INTRAVITREAL RANIBIZUMAB TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Narayan, Daniel
    Meucke, James
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 113 - 113
12345